Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001185185-25-000906
Filing Date
2025-08-07
Accepted
2025-08-06 17:38:40
Documents
107
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K qntm6k073125.htm   iXBRL 6-K 26861
2 EXHIBIT 99.1 qntmex99-1.htm   iXBRL EX-99.1 1267342
3 EXHIBIT 99.2 qntmex99-2.htm EX-99.2 634696
  Complete submission text file 0001185185-25-000906.txt   8923384

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE qntm-20250630.xsd EX-101.SCH 151265
5 XBRL CALCULATION FILE qntm-20250630_cal.xml EX-101.CAL 50805
6 XBRL DEFINITION FILE qntm-20250630_def.xml EX-101.DEF 395961
7 XBRL LABEL FILE qntm-20250630_lab.xml EX-101.LAB 828183
8 XBRL PRESENTATION FILE qntm-20250630_pre.xml EX-101.PRE 421696
109 EXTRACTED XBRL INSTANCE DOCUMENT qntm6k073125_htm.xml XML 1390475
Mailing Address 55 UNIVERSITY AVENUE, SUITE 1003 TORONTO Ontario, Canada M5J 2H7
Business Address 55 UNIVERSITY AVENUE, SUITE 1003 TORONTO Ontario, Canada M5J 2H7 (416) 854-8884
Quantum Biopharma Ltd. (Filer) CIK: 0001771885 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 251190829
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)